AAMI News April 2018, Volume 53, Issue 4
Hospitals as we know them, sprawling buildings or campuses that treat everything from strokes to pneumonia, are undergoing radical changes.
The medical device industry is asking the FDA's Center for Devices and Radiological Health (CDRH)for more regulatory slack on issues ranging from labeling requirements to malfunction reporting.
The FDA has issued a final rule updating how the agency will evaluate clinical data from medical device investigations conducted outside the United States.
After three years of promoting the continuous electronic monitoring of patients on opioids, one of the AAMI Foundation’s initial coalitions has disbanded. A second coalition, focused on infusion, winds down this year.
- News in Brief
- Class II Devices, Implantables Lead the Way in FDA Database
- Shrinking Imaging Equipment Provides Bigger Opportunities
- Tips for Reducing Imaging Service Costs
- AAMI Education Takes Root in Asia
- AAMI Conference Attendees to Run for Fun—and a Good Cause
- When Disaster Strikes: How HTM Rises to the Occasion
- The Big Picture: AAMI Industry Training
- Asked & Answered: Maintaining Hospital Beds
- Career Center: Ways to Keep HTM from Becoming a ‘Starter Career’
- One on One with David Darnel
- AAMI All Star: Joseph Dysko
- Members on the Move
- Standards Spotlight: FDA Considering Updates to Quality System Requirements
- Advertisers in this Issue